SAGE THERAPEUTICS INC (SAGE) Institutional Ownership
None of the superinvestors we track currently report SAGE THERAPEUTICS INC (SAGE) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in SAGE THERAPEUTICS INC (SAGE), this page will show asset manager ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q2 2025 | 1 | $10,154,208 | 1,113,400 |
| Q1 2025 | 1 | $6,119,115 | 769,700 |
| Q4 2024 | 1 | $2,447,817 | 450,795 |
| Q3 2024 | 1 | $3,706,026 | 513,300 |
| Q2 2024 | 1 | $6,009,881 | 553,396 |
| Q1 2024 | 1 | $658 | 35,100 |
| Q3 2023 | 1 | $1,762 | 85,600 |
| Q3 2022 | 1 | $497 | 12,700 |
| Q2 2022 | 1 | $1,402 | 43,400 |
| Q2 2020 | 1 | $11,884 | 285,800 |
| Q1 2020 | 1 | $21,458 | 747,132 |
| Q4 2019 | 1 | $7,984 | 110,591 |
Related SAGE Institutional Insights:
- SAGE Institutional Ownership & Insiders Activity
- SAGE Institutional Ownership & 13F Activity
- SAGE Top Institutional Shareholders
- SAGE Institutional Buying Activity
- SAGE Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- SAGE Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings